Our research has demonstrated that SGLT-2 inhibitors is a safe and effective oral anti-diabetic therapy that can help individuals with diabetes who are currently using glucose-lowering oral anti-diabetic medications. The gene discussed is SLC5A2; the disease is diabetes mellitus.